SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-21-308105
Filing Date
2021-10-26
Accepted
2021-10-26 17:09:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1 d162874ds1.htm S-1 521860
2 EX-1.1 d162874dex11.htm EX-1.1 190950
3 EX-5.1 d162874dex51.htm EX-5.1 11589
4 EX-23.1 d162874dex231.htm EX-23.1 1568
5 GRAPHIC g162874dsp084.jpg GRAPHIC 3902
6 GRAPHIC g162874dsp085.jpg GRAPHIC 2481
7 GRAPHIC g162874g44t14.jpg GRAPHIC 120064
8 GRAPHIC g162874g92m89.jpg GRAPHIC 66393
  Complete submission text file 0001193125-21-308105.txt   988978
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-260508 | Film No.: 211349546
SIC: 2836 Biological Products, (No Diagnostic Substances)